Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChina Pacific Regulatory News (CPIC)

Share Price Information for China Pacific (CPIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.30
Bid: 17.60
Ask: 17.90
Change: 0.00 (0.00%)
Spread: 0.30 (1.705%)
Open: 17.30
High: 0.00
Low: 0.00
Prev. Close: 17.30
CPIC Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

24 Jun 2020 07:00

RNS Number : 8584Q
UBS AG London Branch
24 June 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

 

24 June 2020

 

China Pacific Insurance (Group) Co., LTD.

Mid-stabilisation Period Notice 

 

Further to the pre-stabilisation period announcement dated 16 June 2020, UBS AG London Branch (Contact: Francois-Olivier Mercier, Syndicate Desk: +44 20756 87504) hereby gives notice that stabilisation (within the meaning of Commission Delegated Regulation (EU) 2016/1052 supplementing the Market Abuse Regulation (EU) 596/2014) in relation to the offer of the following securities undertook by it or any of its affiliates in accordance with the rules of the Financial Conduct Authority.

 

The securities:

Issuer:

China Pacific Insurance (Group) Co., LTD.

Securities:

Global Depositary Receipts ("GDRs") each representing 5 A shares of the Company

ISIN:

US16951T1198

Offering size:

Institutional Offering: 102,873,300GDRs (excluding the over-allotment option)

Market:

London Stock Exchange plc, Shanghai-London Stock Connect segment

Ticker:

CPIC

Description:

Initial Public Offering of GDRs

Offer price:

US$ 17.60 per GDR

Associated securities:

There are no associated instruments that are subject to stabilisation

Stabilising Manager:

UBS AG London Branch, 5 Broadgate, London. EC2M 2QS 

 

For each of the dates during which stabilisation transactions were carried out, the price range was as follows:

 

Trade Date

Lowest price (US$)

Highest price (US$)

Trading Venue

17/06/2020

17.60

17.60

LSE

 

 

Important legal information

The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed by any person for any purpose on the information contained in this announcement or its accuracy, fairness or completeness.

This announcement is not for publication or distribution, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia, Canada, Japan, South Africa or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement is not an offer to sell, or solicitation of an offer to buy, acquire or subscribe for any securities to any person in the United States (including its territories and possessions, any state of the United States and the District of Columbia) or in any other jurisdiction in which such offer or solicitation would be unlawful. The GDRs have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of any State or other jurisdiction of the United States and may not be offered or sold in the United States unless registered under the Securities Act or pursuant to or an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and any applicable state or local securities law. The Company has not intended and does not intend to make any public offer of securities in the United States. Any public offering of securities to be made in the United States will be made by means of a prospectus that may be obtained from the Company and that will contain detailed information about the Company and management, as well as financial statements.

In any member state of the European Economic Area (the "EEA") (each, a "Relevant Member State"), this announcement and the Offering are only addressed to and directed at persons who are "qualified investors" ("Qualified Investors") within the meaning of the Regulation (EU) 2017/1129 (the "Prospectus Regulation").

In the United Kingdom, this announcement and any offer if made subsequently is only addressed to and directed at Qualified Investors (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), (ii) high net worth entities who fall within Article 49(2)(a) to (d) of the Order, or (iii) to whom it may otherwise lawfully be communicated (all such persons being referred to as "relevant persons"). This announcement must not be acted on or relied on (i) in the United Kingdom, by persons who are not relevant persons, and (ii) in any member state of the EEA, by persons who are not Qualified Investors. Any investment or investment activity to which this announcement relates is available only to and will only be engaged with (i) in the United Kingdom, relevant persons, and (ii) in any member state of the EEA, Qualified Investors and other persons who are permitted to subscribe for the GDRs described herein pursuant to an exemption from the Prospectus Regulation and other applicable legislation, and will only be engaged in with such persons.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAFJMBTMTMTTMM
Date   Source Headline
28th Apr 20224:01 pmRNSNotice of 2021 AGM
25th Apr 20227:00 amRNS2021 Sustainability Report
14th Apr 202211:59 amRNSAnnouncement relating to Premium Income
28th Mar 20227:00 amRNSPublication of 2021 Annual Results Presentation
28th Mar 20227:00 amRNSProposed amendments to the AoA
28th Mar 20227:00 amRNS2021 Annual Report
28th Mar 20227:00 amRNSPublication of Summaries of Solvency Reports
17th Mar 202212:26 pmRNSConvening of 2021 Annual Results Presentation
10th Mar 20229:26 amRNSAnnouncement relating to Premium Income
15th Feb 20229:21 amRNSAnnouncement relating to Premium Income
19th Jan 202210:44 amRNSPDMR Shareholding
19th Jan 202210:35 amRNSDirector/PDMR Shareholding
19th Jan 202210:32 amRNSAnnouncement relating to Premium Income
14th Jan 202210:59 amRNSDirector/PDMR Shareholding
14th Jan 202210:55 amRNSDirector/PDMR Shareholding
14th Jan 202210:54 amRNSDirector/PDMR Shareholding
17th Dec 20211:27 pmRNSPDMR Shareholding
13th Dec 20219:25 amRNSAnnouncement relating to Premium Income
2nd Dec 20217:00 amRNSPDMR Shareholding
24th Nov 20212:06 pmRNSAnnouncement
12th Nov 20219:37 amRNSCompletion of Change of Registered Capital
12th Nov 20219:34 amRNSAnnouncement relating to Premium Income
29th Oct 202111:15 amRNSProposed Change of Auditors
29th Oct 202111:01 amRNSPublication of Summaries of Solvency Reports
29th Oct 202110:52 amRNS2021 Third Quarter Report
15th Oct 20219:31 amRNSAnnouncement relating to Premium Income
24th Sep 20219:34 amRNSApproval of Articles of Association by CBIRC
16th Sep 202110:00 amRNSAnnouncement relating to Premium Income
1st Sep 20217:00 amRNSPublication of 2021 Interim Results Presentation
1st Sep 20217:00 amRNSPublication of Summaries of Solvency Reports
1st Sep 20217:00 amRNS2021 Interim Report
20th Aug 202111:16 amRNSConvening of 2021 Interim Results Presentation
13th Aug 20219:42 amRNSAnnouncement relating to Premium Income
14th Jul 20219:54 amRNSAnnouncement relating to Premium Income
11th Jun 20219:58 amRNSAnnouncement relating to Premium Income
10th Jun 202110:30 amRNSPDMR Shareholding
4th Jun 202110:20 amRNSChairman of a Subsidiary
3rd Jun 20217:00 amRNSPDMR Shareholding
1st Jun 20217:00 amRNS2020 ESG Report
28th May 20211:31 pmRNSResult of AGM
28th May 202112:54 pmRNSResignation of Vice President
28th May 202112:48 pmRNSAnnouncement re Approval of Appt Qualification
24th May 202110:19 amRNSChange of Venue of the 2020 Annual General Meeting
21st May 202110:15 amRNSAnnouncement regarding GDRs in public hands
11th May 202110:00 amRNSAnnouncement relating to Premium Income
28th Apr 202112:46 pmRNS2021 First Quarter Report
28th Apr 202112:45 pmRNSPublication of Summaries of Solvency Reports
23rd Apr 20211:00 pmRNSNotice of the 2020 Annual General Meeting
14th Apr 202111:02 amRNSAnnouncement relating to Premium Income
7th Apr 202111:47 amRNSApproval of Director's Appointment Qualification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.